{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T16:23:29Z","timestamp":1777134209140,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007950","name":"Tanta University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007950","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Diabetic kidney disease (DKD) is one of the most serious microvascular complications of diabetes mellitus (DM) and the leading cause of chronic kidney disease (CKD) worldwide. Since obesity and type 2 DM (T2DM) are considered as inflammatory conditions, thus reducing their accompanied systemic inflammation may lessen their complications. Sestrin 2 belongs to a group of stress induced proteins which are produced in response to oxidative stress, inflammation and DNA damage. Betatrophin; a hormone that stimulates the growth, proliferation and mass expansion of pancreatic beta-cells and improves glucose tolerance. The objective of the study was to evaluate levels of serum Sestrin 2 and betatrophin in patients with different stages of diabetic nephropathy (DN)) and compare results with healthy control.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross sectional study was carried out on 60 patients above 18 years old, recruited from Tanta University hospitals out patients clinics and 20 apparently healthy individuals of matched sex and age as a control group. Participants were divided into two groups: group I: 20 normal subjects as control group and group II: 60 patients with type 2 DM,. further subdivided in to three equal groups: group 1IIA(20 patients) with normo-albuminuria (ACR\u2009&lt;\u200930\u00a0mg\/g), group IIB (20 patients) with micro albuminuria (ACR\u2009=\u200930 to 300\u00a0mg\/g) and group IIC (20 patients) with macro albuminuria (ACR\u2009&gt;\u2009300\u00a0mg\/g). They were subjected to detailed history taking, careful clinical examination and laboratory investigations including blood urea, serum creatinine, estimated glomerular filtration rate (eGFR), urinary albumin creatinine ratio, and specific laboratory tests for Sestrin 2 and Betatrophin by using ELISA technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum Sestrin 2 significantly decreased, while serum betatrophin level significantly increased in macroalbuminuric group compared to control and other 2 diabetic groups (<jats:italic>P<\/jats:italic>\u2009value\u2009&lt;\u20090.05). The cut off value of serum sestrin 2 was 0.98 ng\/ml with sensitivity 99%, specificity 66% while the cut off value of serum betatrophin was &gt;\u200998.25 ng\/ml with sensitivity 98%, specificity 82%. Serum betatrophin positively correlated with age, fasting, 2\u00a0h postprandial, BMI, triglyceride, total cholesterol, serum creatinine, blood urea, UACR, and negatively correlated with eGFR and serum albumin. Serum Sestrin 2 positively correlated with serum albumin. BMI, serum urea, UACR and serum albumin. Serum betatrophin are found to be risk factors or predictors for diabetic nephropathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Patients with DN, particularly the macroalbuminuria group, had a significant increase in betatrophin levels and a significant decrease in serum Sestrin 2 level. The function of Sestrin 2 is compromised in DN, and restoring it can reverse a series of molecular alterations with subsequent improvement of the renal functions, albuminuria and structural damage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-024-03663-2","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:01:46Z","timestamp":1721404906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy"],"prefix":"10.1186","volume":"25","author":[{"given":"Asmaa Mounir","family":"Emara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal Said","family":"El Bendary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila Mahmoud","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa Ibrahim","family":"Okda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"issue":"4","key":"3663_CR1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.5114\/aoms.2016.58928","volume":"13","author":"MS -Ellulu","year":"2017","unstructured":"-Ellulu MS, Patimah I, Khaza\u2019ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851\u201363.","journal-title":"Arch Med Sci"},{"issue":"2","key":"3663_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1046\/j.1523-1755.2001.059002702.x","volume":"59","author":"P -Hovind","year":"2001","unstructured":"-Hovind P, Rossing P, Tarnow L, Smidt UM. Parving HH.Progression of diabetic nephropathy. Kidney Int. 2001;59(2):702\u20139.","journal-title":"Kidney Int"},{"key":"3663_CR3","first-page":"1199","volume-title":"Oxford textbook of clinical nephrology","author":"L -Gnudi","year":"2016","unstructured":"-Gnudi L, Gentile G, Ruggenenti P. The patient with diabetes mellitus. In: Turner N, Lamiere N, Goldsmith DJ, Wineearls CG, Himmelfarb J, Remuzzi G, editors. Oxford textbook of clinical nephrology. Volume 2. Oxford: Oxford University Press; 2016. pp. 1199\u2013247."},{"issue":"4","key":"3663_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/BF00285287","volume":"32","author":"T Deckert","year":"1989","unstructured":"Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia. 1989;32(4):219\u201326.","journal-title":"Diabetologia"},{"issue":"10","key":"3663_CR5","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.2215\/CJN.00580111","volume":"6","author":"AM -Berhane","year":"2011","unstructured":"-Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death. Clin J Am Soc Nephrol. 2011;6(10):2444\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3663_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41467-019-13442-5","volume":"11","author":"M -Kim","year":"2020","unstructured":"-Kim M, Sujkowski A, Namkoong S, Gu B, Cobb T, Kim B, Kowalsky AH, Cho CS, Semple I, Ro SH, Davis C, Brooks SV, Karin M, Wessells RJ, Lee JH. Sestrins are evolutionarily conserved mediators of exercise benefits. Nat Commun. 2020;11:190.","journal-title":"Nat Commun"},{"key":"3663_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.14336\/AD.2019.0320","volume":"11","author":"W -Sun","year":"2020","unstructured":"-Sun W, Wang Y, Zheng Y, Quan N. The emerging role of Sestrin2 in cell metabolism, and Cardiovascular and Age-Related diseases. Aging Dis. 2020;11:154\u201363.","journal-title":"Aging Dis"},{"key":"3663_CR8","doi-asserted-by":"publisher","first-page":"111251","DOI":"10.1016\/j.mad.2020.111251","volume":"188","author":"X -Fan","year":"2020","unstructured":"-Fan X, Zeng Y, Song W, Li J, Ai S, Yang D, Mao X, Yang M. The role of Sestrins in the regulation of the aging process. Mech Ageing Dev. 2020;188:111251.","journal-title":"Mech Ageing Dev"},{"key":"3663_CR9","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s40618-020-01429-9","volume":"44","author":"S -Sundararajan","year":"2021","unstructured":"-Sundararajan S, Jayachandran I, Subramanian SC, Anjana RM, Balasubramanyam M, Mohan V, Venkatesan B, Manickam N. Decreased sestrin levels in patients with type 2 diabetes and dyslipidemia and their association with the severity of atherogenic index. J Endocrinol Invest. 2021;44:1395\u2013405.","journal-title":"J Endocrinol Invest"},{"key":"3663_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s40200-020-00498-0","volume":"19","author":"KM -Mohany","year":"2020","unstructured":"-Mohany KM, Al Rugaie O. Association of serum sestrin 2 and betatrophin with serum neutrophil gelatinase associated lipocalin levels in type 2 diabetic patients with diabetic nephropathy. J Diabetes Metab Disord. 2020;19:249\u201356.","journal-title":"J Diabetes Metab Disord"},{"key":"3663_CR11","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/db19-0991","volume":"69","author":"X -Sun","year":"2020","unstructured":"-Sun X, Han F, Lu Q, Li X, Ren D, Zhang J, Han Y, Xiang YK, Li J. Empagliflozin ameliorates obesity-related Cardiac Dysfunction by regulating Sestrin2-Mediated AMPK-mTOR Signaling and Redox Homeostasis in High-Fat Diet-Induced obese mice. Diabetes. 2020;69:1292\u2013305.","journal-title":"Diabetes"},{"key":"3663_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.diabres.2018.07.024","volume":"144","author":"HS -Chung","year":"2018","unstructured":"-Chung HS, Hwang HJ, Hwang SY, et al. Association of serum Sestrin2 level with metabolic risk factors in newly diagnosed drug-na\u00efve type 2 diabetes. Diabetes Res Clin Pract. 2018;144:34\u201341.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"3663_CR13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"R Zhang","year":"2012","unstructured":"Zhang R. Lipasin, a novel nutritionally-regulated liverenriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424(4):786\u201392.","journal-title":"Biochem Biophys Res Commun"},{"key":"3663_CR14","doi-asserted-by":"crossref","unstructured":"Zhang -DiYanJuan, Yu FS, Xu et al. Recombinant betatrophin (Angptl-8\/lipasin) ameliorates streptozotocininduced hyperglycemia and \u03b2cell destruction in neonatal rats Molecular Medicine Reports., 2019;20: 4523\u20134532.","DOI":"10.3892\/mmr.2019.10719"},{"key":"3663_CR15","doi-asserted-by":"crossref","unstructured":"Gusarova -V, Alexa C, Na E et al. ANGPTL8\/betatrophin does not controlpancreatic beta cell expansion. Cell 2014:159(3), 691\u20136.","DOI":"10.1016\/j.cell.2014.09.027"},{"issue":"1","key":"3663_CR16","doi-asserted-by":"publisher","first-page":"E96","DOI":"10.1210\/jc.2014-2300","volume":"100","author":"X Chen","year":"2015","unstructured":"Chen X, Lu P, He W, et al. Circulating betatrophin levels are increased in patients with type 2 diabetes and associated with insulin resistance. J Clin Endocrinol Metab. 2015;100(1):E96\u2013100.","journal-title":"J Clin Endocrinol Metab"},{"key":"3663_CR17","doi-asserted-by":"crossref","unstructured":"Zhang -R, Abou-Samra AB. A dual role of lipasin (betatrophin) in lipid metabolism and glucose homeostasis: consensus and controversy. Cardiovasc Diabetol,2014:(13) 133.","DOI":"10.1186\/PREACCEPT-6310273751364807"},{"issue":"1","key":"3663_CR18","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.2337\/dc08-S055","volume":"31","author":"-American Diabetes Association","year":"2008","unstructured":"-American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(1):S55\u201360.","journal-title":"Diabetes Care"},{"key":"3663_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT -Friedewald","year":"1972","unstructured":"-Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499\u2013502.","journal-title":"Clin Chem"},{"key":"3663_CR20","doi-asserted-by":"crossref","unstructured":"-Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J. Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MORD Study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) Study. Am J Kidney Dis Apr 201O; 55(4): 648\u201359.","DOI":"10.1053\/j.ajkd.2009.12.016"},{"key":"3663_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14325","volume":"23","author":"S -Kohsaka","year":"2021","unstructured":"-Kohsaka S, Morita N, Okami S, et al. Current trends in diabetes mellitus database research in Japan. Diabetes Obes Metabolism. 2021;23:3\u201318.","journal-title":"Diabetes Obes Metabolism"},{"key":"3663_CR22","first-page":"1361","volume":"45","author":"Q -Lin","year":"2020","unstructured":"-Lin Q, Ma Y, Chen Z, Hu J, Chen C, Fan Y, et al. Sestrin-2 regulates podocyte mitochondrial dysfunction and apoptosis under high-glucose conditions via AMPK. Int J Mol Med. 2020;45:1361\u201372.","journal-title":"Int J Mol Med"},{"issue":"1","key":"3663_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s10020-022-00580-8","volume":"7","author":"MM -Watany","year":"2022","unstructured":"-Watany MM, El-Horany HE, Elhosary MM, et al. Clinical application of RUBCN\/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease. Mol Med. 2022;7(1):147.","journal-title":"Mol Med"},{"issue":"4","key":"3663_CR24","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2337\/db13-1435","volume":"63","author":"Y Jiao","year":"2014","unstructured":"Jiao Y, Le Lay J, Yu M, Naji A, Kaestner K.H. Elevated mouse hepatic betatrophin expression does not increase human \ud6fd-Cell replication in the transplant setting. Diabetes. 2014;63(4):1283\u20138.","journal-title":"Diabetes"},{"issue":"6","key":"3663_CR25","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.cmet.2014.11.016","volume":"20","author":"-KH Kaestner","year":"2014","unstructured":"Kaestner -KH. Betatrophin\u2014promises fading and lessons learned. Cell Metabol. 2014;20(6):932\u20133.","journal-title":"Cell Metabol"},{"issue":"1","key":"3663_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-015-0324-y","volume":"15","author":"C-C -Hen","year":"2016","unstructured":"-Hen C-C, Susanto H, Chuang W-H, et al. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Cardiovasc Diabetol. 2016;15(1):1.","journal-title":"Cardiovasc Diabetol"},{"key":"3663_CR27","doi-asserted-by":"crossref","unstructured":"-Maurer L, Schwarz F, Fischer-Rosinsky A et al. Renal function is independently associated with circulating betatrophin. PLoS ONE. 2017;12(3). e0173197.","DOI":"10.1371\/journal.pone.0173197"},{"issue":"5","key":"3663_CR28","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/biomedicines12050949","volume":"12","author":"-Eman Alshawaf","year":"2024","unstructured":"Alshawaf -Eman, Abu-Farha M, Mohammad A, et al. Angiopoietin-2 and angiopoietin-like proteins with a prospective role in Predicting Diabetic Nephropathy. Biomedicines. 2024;12(5):949.","journal-title":"Biomedicines"},{"issue":"10","key":"3663_CR29","doi-asserted-by":"publisher","first-page":"E2004","DOI":"10.1210\/jc.2014-1568","volume":"99","author":"E Pascual","year":"2014","unstructured":"-Javier G\u00f3mez-Ambrosi 1, Pascual E, Catal\u00e1n V, et al. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes. J Clin Endocrinol Metab. 2014;99(10):E2004\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03663-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03663-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:03:14Z","timestamp":1721404994000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03663-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3663"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03663-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was done after approval from the Ethical Committee Tanta university, Research ethics committee review report approval code 34548\/3\/21 and was in accordance with the principles of the Declaration of Helsinki II, date 9|3|2021.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed written consent was obtained from all patients and participatants included in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}